Nordea Investment Management Ab Astrazeneca PLC Transaction History

Nordea Investment Management Ab

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 19, 2022	SELL	$53.02 - $135.75 $2.62 Million - $6.71 Million	-49,449 Reduced 66.14%	25,319 $1.4 Million
Q2 2022 Aug 09, 2022	SELL	$59.26 - $71.14 $1.61 Million - $1.93 Million	-27,154 Reduced 26.64%	74,768 $4.89 Million
Q1 2022 Apr 11, 2022	SELL	$55.72 - $67.12 $347,525 - $418,627	-6,237 Reduced 5.77%	101,922 $6.87 Million
Q4 2021 Jan 20, 2022	SELL	$54.02 - $63.83 $107,121 - $126,574	-1,983 Reduced 1.8%	108,159 $6.33 Million
Q3 2021 Nov 01, 2021	SELL	$55.56 - $60.79 $6.12 Million - $6.7 Million	-110,142 Reduced 50.0%	110,142 $6.64 Million
Q3 2021 Nov 01, 2021	BUY	$55.56 - $60.79 $12.2 Million - $13.4 Million	220,284 New	220,284 $13.2 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

Stay updated on Nordea Investment Management Ab with notifications on news.